POSSIBLE DA AGONIST PROPERTIES OF NALOXONEFEIGENBAUM J; YANAI J; BLASS R et al.1982; INTERNATIONAL JOURNAL OF NEUROSCIENCE; ISSN 0020-7454; GBR; DA. 1982; VOL. 17; NO 3; PP. 139-144; BIBL. 2 P.Article

DOPAMINREZEPTOREN1-STIMULATOREN IN DER BEHANDLUNG DER PARKINSONKRANKHEIT = STIMULANTS DOPAMINERGIQUES DANS LE TRAITEMENT DE LA MALADIE DE PARKINSONRINGWALD E; HIRT D; MARKSTEIN R et al.1982; NERVENARZT; ISSN 0028-2804; DEU; DA. 1982; VOL. 53; NO 2; PP. 67-71; BIBL. 41 REF.Article

I NUOVI INIBITORI DELLA LATTAZIONE = LES NOUVEAUX INHIBITEURS DE LA LACTATIONBAGNOLI P; ZOCCHI G.1979; MINERVA GINECOL.; ITA; DA. 1979; VOL. 31; NO 4; PP. 245-250; ABS. ENG; BIBL. 21 REF.Article

CHRONIC DOPAMINERGIC SENSITIVITY AFTER SYDENHAM'S CHOREANAUSIEDA PA; BIELIAUSKAS LA; BACON LD et al.1983; NEUROLOGY; ISSN 0028-3878; USA; DA. 1983; VOL. 33; NO 6; PP. 750-754; BIBL. 31 REF.Article

THE USE OF LISURIDE, A POTENT DOPAMINE AND SEROTONIN AGONIST IN THE TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSYNEOPHYTIDES A; LIEBERMAN AN; GOLDSTEIN M et al.1982; J. NEUROL. NEUROSURG. PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1982; VOL. 45; NO 3; PP. 261-263; BIBL. 23 REF.Article

BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF APOMORPHINE IN THE CATTRULSON ME; CRISP T.1982; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1982; VOL. 80; NO 4; PP. 295-309; BIBL. 2 P.Article

EFFECTIVENESS OF PERGOLIDE MESYLATE IN LONG TERM TREATMENT OF HYPERPROLACTINAEMIAFRANKS S; HORROCKS PM; LYNCH SS et al.1983; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1983; VOL. 286; NO 6372; PP. 1177-1179; BIBL. 10 REF.Article

LISURIDE AND PERGOLIDE IN PARKINSON'S DISEASELANG AE; SHEEHY MP; QUINN NP et al.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 109-120; BIBL. 10 REF.Article

SUPPRESSION OF BASAL AND STIMULATED NORADRENERGIC ACTIVITIES BY THE DOPAMINE AGONIST BROMOCRIPTINE IN MANCAREY RM; VAN LOON GR; BAINES AD et al.1983; JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM; ISSN 0021-972X; USA; DA. 1983; VOL. 56; NO 3; PP. 595-602; BIBL. 56 REF.Article

EFFECTS OF BROMOCRIPTINE ON SINGLE NEPHRON AND WHOLE-KIDNEY FUNCTION IN RATSSTIER CT JR; COWDEN EA; ALLISON MEM et al.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 2; PP. 366-370; BIBL. 22 REF.Article

EFFECT OF BROMOCRIPTINE ON THYROID HORMONE-INDUCED GROWTH HORMONE PRODUCTION IN CULTURED GH₁ CELLSTSAI JS; PASQUAL A.1981; ENDOCRINOLOGY (PHILADELPHIA); ISSN 0013-7227; USA; DA. 1981; VOL. 109; NO 4; PP. 1306-1308; BIBL. 22 REF.Article

ELEVATION OF SERUM CORTICOSTERONE CONCENTRATIONS IN RATS BY PERGOLIDE AND OTHER DOPAMINE AGONISTSFULLER RW; SNODDY HD.1981; ENDOCRINOLOGY (PHILADELPHIA); ISSN 0013-7227; USA; DA. 1981; VOL. 109; NO 4; PP. 1026-1032; BIBL. 30 REF.Article

STRIATAL MUSCARINIC RECEPTORS: REGULATION BY DOPAMINERGIC AGONISTSEHLERT FJ; ROESKE WR; YAMAMURA HI et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 21; PP. 2441-2448; BIBL. 20 REF.Article

SINDROME PREMESTRUALE E BROMOCRIPTINA = SYNDROME PREMENSTRUEL ET BROMOCRIPTINETOLINO A; CARDONE A; DE CONCILIS B et al.1977; RIV. ITAL. GINECOL.; ITA; DA. 1977; VOL. 58; NO 5; PP. 379-383; ABS. ENG; BIBL. 18 REF.Article

STEREOTYPED BEHAVIOR AFFECTED BY PERIPHERAL AND INTRACEREBROVENTRICULAR APOMORPHINE ADMINISTRATION IN PIGEONSDEVICHE P.1983; PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR; ISSN 0091-3057; USA; DA. 1983; VOL. 18; NO 3; PP. 323-326; BIBL. 16 REF.Article

ANTIPARKINSONIAN AND ANTIDEPRESSANT EFFECTS OF HIGH DOSES OF BROMOCRIPTINE: AN INDEPENDENT COMPARISONJOUVENT R; ABENSOUR P; BONNET AM et al.1983; JOURNAL OF AFFECTIVE DISORDERS; ISSN 0165-0327; NLD; DA. 1983; VOL. 5; NO 2; PP. 141-145; BIBL. 17 REF.Article

IS TL-99 A SELECTIVE PRESYNAPTIC DOPAMINE RECEPTOR AGONIST.HORN AS; DE VRIES J; DIJKSTRA D et al.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 83; NO 1-2; PP. 35-45; BIBL. 2 P.Article

JUMPING BEHAVIOR INDUCED BY THYROTROPIN RELEASING HORMONE IN COMBINATION WITH APOMORPHINE IN MICEUSHIJIMA I; YAMADA K; NODA Y et al.1982; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1982; VOL. 76; NO 1; PP. 1-4; BIBL. 35 REF.Article

PIRIBEDIL-INDUCED ANTI-HYPOXIC PROTECTION IN RATSSALIGAUT C; MOORE N; DAOUST M et al.1982; AVIAT., SPACE, ENVIRON. MED.; ISSN 0095-6562; USA; DA. 1982; VOL. 53; NO 1; PP. 35-39; BIBL. 16 REF.Article

DIFFERENT EFFECTS OF APOMORPHINE ON LOCOMOTOR ACTIVITY IN C57BL/6 AND DBA/2 MICESANSONE M; AMMASSARI TEULE M; RENZI P et al.1981; PHARMACOL., BIOCHEM. BEHAV.; ISSN 0091-3057; USA; DA. 1981; VOL. 14; NO 5; PP. 741-743; BIBL. 13 REF.Article

LE TEST A LA NOMIFENSINE DANS L'EXPLORATION DYNAMIQUE DE LA SECRETION DE LA PROLACTINEMIZRAHI R; CHANSON B; DEFAY E et al.1980; REV. FR. ENDOCRINOL. CLIN., NUTR. METAB.; ISSN 0048-8062; FRA; DA. 1980; VOL. 21; NO 4; PP. 295-307; ABS. ENG; BIBL. 20 REF.Article

BINDING OF (³H) PERGOLIDE MESYLATE TO DOPAMINE RECEPTORS OF MAMMALIAN BRAINSWONG DT; BYMASTER FP; LANE PT et al.1980; RES. COMMU. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1980; VOL. 30; NO 2; PP. 195-210; BIBL. 2 P.Article

BROMOCRIPTINE INHIBITS NOREPINEPHRINE RELEASEZIEGLER MG; LAKE CR; WILLIAMS AC et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 2; PP. 137-142; BIBL. 28 REF.Article

THE EFFECTS OF PERGOLIDE ON THE CARDIOVASCULAR SYSTEM OF 40 PATIENTS WITH PARKINSON'S DISEASELEIBOWITZ M; LIEBERMAN AN; NEOPHYTIDES A et al.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 121-130; BIBL. 24 REF.Article

A 6-MONTH TRIAL OF PERGOLIDE MESYLATE ON THE TREATMENT OF IDIOPATHIC PARKINSON'S DISEASEKLAWANS HL; TANNER CM; GLATT S et al.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 75-83; BIBL. 29 REF.Article